Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
Open Access
- 15 May 1995
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 14 (10) , 2176-2182
- https://doi.org/10.1002/j.1460-2075.1995.tb07211.x
Abstract
Using a three‐dimensional model of G protein‐coupled receptors (GPCR), we have previously succeeded in docking the neurohypophysial hormone arginine‐vasopressin (AVP) into the V1a receptor. According to this model, the hormone is completely embedded in the transmembrane part of the receptor. Only the side chain of the Arg residue at position 8 projects outside the transmembrane core of the receptor and possibly interacts with a Tyr residue located in the first extracellular loop at position 115. Residue 8 varies in the two natural neurohypophysial hormones, AVP and oxytocin (OT); similarly, different residues are present at position 115 in the different members of the AVP/OT receptor family. Here we show that Arg8 is crucial for high affinity binding of AVP to the rat V1a receptor. Moreover, when Tyr115 is replaced by an Asp and a Phe, the amino acids naturally occurring in the V2 and in the OT receptor subtypes, the agonist selectivity of the V1a receptor switches accordingly. Our results indicate that the interaction between peptide residue 8 and the receptor residue at position 115 is not only crucial for agonist high affinity binding but also for receptor selectivity.Keywords
This publication has 31 references indexed in Scilit:
- Locating ligand-binding sites in 7tm receptors by protein engineeringCurrent Opinion in Biotechnology, 1994
- STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORSAnnual Review of Biochemistry, 1994
- Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surfaceNature, 1994
- Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptorBiochemistry, 1993
- Projection structure of rhodopsinNature, 1993
- Mutagenesis of the beta2-Adrenergic Receptor: How Structure Elucidates FunctionAnnual Review of Pharmacology and Toxicology, 1992
- Conformational and Structural Considerations in Oxytocin-Receptor Binding and Biological ActivityAnnual Review of Pharmacology and Toxicology, 1990
- Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes InsipidusNew England Journal of Medicine, 1988
- Amino‐aromatic interactions in proteinsFEBS Letters, 1986
- (3H)-Vasopressin Binding to Isolated Rat Hepatocytes and Liver Membranes: Regulation by GTP and Relation to Glycogen Phosphorylase ActivationJournal of Receptor Research, 1980